IZMO Limited Q2 FY27 Revenue Rises 10.4% to ₹66.35 Crore

IZMO Limited reported consolidated revenue of ₹66.35 crore for Q2 FY27, up 10.4% year on year and 1.5% sequentially, while consolidated net profit was ₹12.50 crore. The July-September 2026 quarter also included employee stock option actions and a rise in the company’s paid-up share capital.

What did IZMO report for Q2 FY27?

IZMO reported consolidated revenue of ₹66.35 crore and consolidated net profit of ₹12.50 crore for the quarter ended September 2026. The result was approved by the board on 13 November 2026, when it considered the company’s Q2 FY27 financial statements.

The quarter is significant because it follows a volatile recent revenue trend. In Q1 FY27, IZMO had reported revenue from operations of ₹65.38 crore and net profit of ₹12.20 crore. The Q2 outcome indicates a modest sequential increase in both reported revenue and profit after the June quarter.

How did revenue and profit compare with earlier periods?

IZMO’s revenue rose 1.5% from the preceding quarter and 10.4% from the comparable quarter a year earlier. This places Q2 FY27 revenue slightly above the ₹65.38 crore recorded in Q1 FY27, when revenue had fallen 40.1% from the March 2026 quarter.

Net profit increased 2.5% from Q1 FY27 to ₹12.50 crore in Q2 FY27. However, profit was 0.5% lower than the year-earlier quarter. The difference between revenue growth and profit movement shows that the company’s year-on-year earnings did not rise at the same pace as its reported revenue during the quarter.

For context, IZMO reported annual revenue of ₹284.88 crore and annual net profit of ₹47.56 crore in FY26. Its June 2026 quarterly operating profit was ₹16.39 crore, while EBITDA was ₹16.74 crore. The Q2 disclosure provided revenue and net-profit growth rates but did not provide comparable operating-profit or EBITDA figures in the supplied results summary.

What decisions did IZMO’s board approve alongside the results?

IZMO’s board allotted 50,726 equity shares under its employee stock option plan and granted 116,050 options at an exercise price of ₹10 per option. These actions were disclosed alongside the approval of the Q2 FY27 financial results.

Following the share allotment, the company’s paid-up share capital increased to ₹15.03 crore. The allotted shares are relevant to investors because employee option exercises increase the number of outstanding equity shares, although the supplied information does not state the timing of future option vesting or exercise.

The board meeting followed the closure of the trading window from 1 October 2026 in connection with the quarterly results process. IZMO had earlier notified the market that the board would meet on 13 November to consider the July-September quarter results.

What did the limited-review reports note?

The limited-review reports noted that certain balances were pending confirmation and reconciliation. This disclosure relates to the review of the quarterly financial statements and forms part of the information investors should consider alongside the reported revenue and profit figures.

The supplied material does not quantify the balances concerned or state an effect on the reported Q2 revenue or net profit. It also does not provide details of any subsequent adjustment. The reported figures therefore remain the results approved by the board, with the review observation disclosed as part of the accompanying financial-reporting process.

Such observations are relevant because quarterly results are prepared and reviewed under the reporting requirements applicable to listed companies. Investors typically track whether pending confirmations or reconciliations are resolved in later financial statements and whether they lead to any revisions or further disclosures.

Why do IZMO’s Q2 FY27 results matter to investors?

IZMO’s Q2 figures provide an update on performance after a June quarter in which revenue grew 15.7% year on year but declined 40.1% sequentially from Q4 FY26. The 1.5% sequential revenue increase in Q2 is therefore a data point on the company’s progress after that sharp quarter-on-quarter decline.

The company had previously guided for FY27 revenue of ₹45 crore to ₹50 crore for its izmoMicro division. The Q2 consolidated result does not disclose the division’s revenue separately, so the extent of progress against that specific subsidiary guidance cannot be determined from the information provided.

Before the Q2 result, IZMO’s stated market capitalisation was ₹1,294.75 crore and its share price was ₹864.30, based on data dated 12 November 2026. No share-price reaction to the Q2 announcement is included in the supplied material. For shareholders, the key reported measures are the 10.4% year-on-year revenue increase, the 0.5% year-on-year decline in net profit, and the increase in paid-up capital after the ESOP allotment.

Conclusion

IZMO delivered Q2 FY27 consolidated revenue of ₹66.35 crore and net profit of ₹12.50 crore, representing modest sequential growth in both measures. Revenue increased 10.4% from a year earlier, while net profit was 0.5% lower, and the board also completed ESOP-related allotments and grants.

Investors will watch for updates on the pending balance confirmations and reconciliations noted in the limited-review reports. They will also track IZMO’s progress towards the ₹45 crore to ₹50 crore FY27 revenue guidance for the izmoMicro division, as well as future disclosures on operating performance and share-capital changes.